Nasdaq-traded Chinese herb stock with no revenues rallies 58,000% to top Lululemon in market value
The developer of traditional Chinese herbal treatments for childhood ADHD and autism is up roughly 58,000% year to date. Original source: https://www.cnbc.com/2025/06/17/hong-kongs-regencell-bioscience-triples-in-latest-surge-for-a-speculative-stock.html
Read More »